◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Koninklijke Philips NV ADR (PHG) Net Income 2006–TTM

Name: Koninklijke Philips NV ADR (PHG) net income history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Koninklijke Philips NV ADR annual net income for fiscal TTM was €1.1 billion, an increase of 24.5% from €895 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

PHG Annual Net Income

Net Income (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Net Income	€1.1B	€895M	(€702M)	(€466M)	(€1.6B)	€3.3B	€1.2B	€1.2B	€1.1B	€1.7B	€1.4B	€645M	€415M	€1.2B	€226M	(€1.3B)	€1.4B	€410M	(€92M)	€4.2B	€5.4B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PHG Quarterly Net Income

Net Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Net Income	€384M	€151M	€395M	€184M	€240M	€76M	(€335M)	€181M	€451M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

PEN Net Income — Penumbra Inc
SNN Net Income — Smith & Nephew SNATS Inc
BIO Net Income — Bio-Rad Laboratories Inc
GMED Net Income — Globus Medical
BIO.B Net Income — Bio-Rad Laboratories Inc
GKOS Net Income — Glaukos Corp

More PHG metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All PHG financial statements → Interactive PHG charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.